Does a novel prediction model accurately predict ventricular arrhythmias across both classical and non-classical arrhythmogenic cardiomyopathy phenotypes?
A novel arrhythmic risk prediction model is effective for classical arrhythmogenic cardiomyopathy but underestimates risk in non-classical phenotypes, highlighting the need for subtype-specific risk stratification.
Non-classical ACM forms appear more prone to VAs than classical forms. The novel prediction model effectively predicted arrhythmic risk in the classical R-ACM cohort, but seemed to underestimate it in non-classical forms.
Casella et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: